000 01352 a2200373 4500
005 20250518085529.0
264 0 _c20210518
008 202105s 0 0 eng d
022 _a1873-3344
024 7 _a10.1016/j.jinorgbio.2019.110981
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKenny, Reece G
245 0 0 _aVorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors.
_h[electronic resource]
260 _bJournal of inorganic biochemistry
_c05 2020
300 _a110981 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
650 0 4 _aAorta
_xdrug effects
650 0 4 _aGuanylate Cyclase
_xmetabolism
650 0 4 _aHydroxamic Acids
_xchemistry
650 0 4 _aNitric Oxide Donors
_xpharmacology
650 0 4 _aRats
650 0 4 _aRuthenium
_xchemistry
650 0 4 _aSulfonamides
_xpharmacology
650 0 4 _aVasodilation
_xdrug effects
650 0 4 _aVasodilator Agents
_xpharmacology
650 0 4 _aVorinostat
_xpharmacology
700 1 _aUde, Ziga
700 1 _aDocherty, James R
700 1 _aMarmion, Celine J
773 0 _tJournal of inorganic biochemistry
_gvol. 206
_gp. 110981
856 4 0 _uhttps://doi.org/10.1016/j.jinorgbio.2019.110981
_zAvailable from publisher's website
999 _c30663713
_d30663713